Across the recent three months, 8 analysts have shared their insights on Ocular Therapeutix (NASDAQ:OCUL), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 4 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 3 | 1 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Ocular Therapeutix and provided 12-month price targets. The average target is $17.5, accompanied by a high estimate of $24.00 and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 66.67% increase from the previous average price target of $10.50.
Diving into Analyst Ratings: An In-Depth Exploration
Login or create a forever free account to read this news
Sign up/Log in